Namilumab

Modify Date: 2024-09-19 13:59:56

Namilumab structure	Common Name	Namilumab
	CAS Number	1206681-39-1	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Namilumab

Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis[1].

Name	Namilumab

Description	Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis[1].
Related Catalog	Research Areas >> Inflammation/Immunology Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Fms
Target	GM-CSF[1]
In Vivo	Namilumab can be used for the research of rheumatoid arthritis with good tolerance[1].
References	[1]. Huizinga TWJ, et, al. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis. Arthritis Res Ther. 2017 Mar 9;19(1):53.

No Any Chemical & Physical Properties

Namilumab

Use of Namilumab

Names

Namilumab Biological Activity

Chemical & Physical Properties